Research & Development
Pathology & AI
Immunoassays: Page 2
QuidelOrtho nabs Health Canada approval for high-sensitivity troponin I test on small-footprint analyzer
The test, a fluorescence immunoassay, runs on the Quidel Triage MeterPro platform and provides a quantitative determination of troponin I in whole blood or plasma specimens as an aid in the diagnosis of myocardial infarction.
December 20, 2022
Test choices for COVID-19, flu confusing for many: new survey
The survey findings are compelling in the context of a potential tripledemic, as influenza, COVID-19, and respiratory syncytial virus cases rise.
December 16, 2022
Exposure to SARS-CoV-2 vaccination and infection may provide more durable immunity: Canadian study
Exposure to vaccination and infection "likely provides stronger, broader, and more durable hybrid immunity than either exposure alone, especially against severe outcomes,” the researchers said.
December 6, 2022
Bio-Techne releases next-generation mitochondrial imaging dyes
The MitoBrilliant probes come in two types: the MitoBrilliant Live, which enables dynamic longer-term monitoring of mitochondrial membrane potential in live cells, and MitoBrilliant 646, to be used postfixation.
December 5, 2022
Pictor launches $5M financing round to support product, market development
Pictor's multiplex technology enables testing for multiple diseases or different stages of a disease within a single enzyme-linked immunosorbent assay (ELISA) test well.
December 5, 2022
CorDx receives FDA Emergency Use Authorization for COVID-19 antigen test
The COVID-19 Ag lateral flow immunoassay provides qualitative detection of the nucleocapsid protein antigen from the SARS-CoV-2 virus, providing a result in 10 minutes.
December 1, 2022
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Quest Diagnostics offers suite of services for transplant patients and living donors
Rapid nirmatrelvir treatment in study reduced long-COVID risk
PerkinElmer launches adeno-associated virus vector detection kits for research
The new kits use bead-based luminescent amplification to provide researchers with an option that is less time-consuming than ELISA and other wash-based tests, as well as having a wide detection range and high throughput.
November 21, 2022
Roche Diagnostics expands retail channel for COVID-19 at-home test
Roche Diagnostics said that their over-the-counter test for SARS-CoV-2 has been rebranded as the Pilot COVID-19 At-Home Test.
November 10, 2022
Nanomix signs distribution agreement with Mast Group for immunoassay and chemistry diagnostic system
Nanomix has signed an agreement with Mast Group, allowing the company to distribute Nanomix’s eLab system to the U.K., France, Germany, Ireland, and South Africa.
November 4, 2022
Lab-based immunoassay products market to reach $30.6B in 2022: Kalorama
The global market for lab-based immunoassay products is expected to grow at a compound annual growth rate (CAGR) of 2% between 2022 and 2027.
October 28, 2022
UCLA research shows rapid antigen tests may be effective tools for return-to-work programs
Researchers from UCLA conducted a study examining how antigen test results may be used to guide healthcare systems implementing return-to-work protocols.
October 24, 2022
Volition signs global supply agreement for pet cancer assay
According to the agreement, the supplier will be engaged as a worldwide provider of the pet cancer assay through its reference laboratory network.
October 20, 2022
Page 2 of 58